Home
Scholarly Works
Nonacog Alfa as Prophylaxis in Moderately Severe...
Conference

Nonacog Alfa as Prophylaxis in Moderately Severe to Severe (FIX:C <= 2%) Hemophilia B Patients: Identifying Clinical Predictors of Response

Authors

Rendo P; Smith L; Carlsson M; Iorio A

Volume

22

Pagination

pp. 69-69

Publisher

WILEY-BLACKWELL

Publication Date

February 1, 2016

Conference proceedings

HAEMOPHILIA

ISSN

1351-8216

Labels

Fields of Research (FoR)

Contact the Experts team